Ventricular Dysfunction in Patients With Congenital Diaphragmatic Hernia Who Die After Repair

Catherine M Avitabile1, Yan Wang2, Devon Ash2

  • 1Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Division of Cardiology and Echocardiography Laboratory Research Unit, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

PubMed

Insights

Smaller left ventricular size in neonates with congenital diaphragmatic hernia (CDH) predicted early mortality after surgical repair. Echocardiography may help stratify risk in these critical patients.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Critical Care
  • Congenital Abnormalities

Background:

  • Pulmonary hypertension (PH) in pediatric patients with congenital diaphragmatic hernia (CDH) is associated with mortality.
  • Quantitative echocardiography (echo) is crucial for assessing ventricular function in PH, but data in CDH survivors are limited.
  • Few studies report quantitative echo data in CDH non-survivors beyond the first week of life.

Purpose of the Study:

  • To investigate quantitative echocardiographic measures of ventricular size and function in neonatal CDH patients who died during hospitalization.
  • To compare echo findings between early (<30 days) and late (>30 days) deaths after surgical repair in CDH patients.

Main Methods:

  • Retrospective, cross-sectional cohort study of CDH patients (2013-2022) who died during neonatal hospitalization after surgical repair.
  • Quantitative echo measures of right (RV) and left ventricular (LV) size and function were analyzed offline on the last echocardiogram before death.
  • Statistical comparison (Wilcoxon rank sum test) of echo data between early and late death groups.

Main Results:

  • Twenty-five deceased CDH patients (11 early, 14 late deaths) were analyzed.
  • Patients who died early had significantly smaller LV end-diastolic dimension Z-scores compared to late deaths.
  • Trends indicated worse RV and LV function in the early death group, including reduced TAPSEZ, RVFAC, and strain parameters.

Conclusions:

  • Ventricular hypoplasia and dysfunction may impact mortality in CDH patients.
  • Quantitative echocardiography findings show potential for risk stratification in CDH, warranting further investigation.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4